Das FH-defiziente Nierenzellkarzinom erweitert das Spektrum der papillären Tumoren in der Niere

por Rupp, N., Moch, H.
Publicado 2021

Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression

por Wyler, L, Napoli, C U, Ingold, B, Sulser, T, Heikenwälder, M, Schraml, P, Moch, H
Publicado 2014

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies

por Huber, F, Montani, M, Sulser, T, Jaggi, R, Wild, P, Moch, H, Gevensleben, H, Schmid, M, Wyder, S, Kristiansen, G
Publicado 2015

Frequent PD-L1 expression in testicular germ cell tumors

por Fankhauser, C D, Curioni-Fontecedro, A, Allmann, V, Beyer, J, Tischler, V, Sulser, T, Moch, H, Bode, P K
Publicado 2015

Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma

por Curioni-Fontecedro, A., Pitocco, R., Schoenewolf, N. L., Holzmann, D., Soldini, D., Dummer, R., Calvieri, S., Moch, H., Mihic-Probst, D., Fitsche, A.
Publicado 2015

Erratum to “Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma”

por Curioni-Fontecedro, A., Pitocco, R., Schoenewolf, N. L., Holzmann, D., Soldini, D., Dummer, R., Calvieri, S., Moch, H., Fitsche, A., Mihic-Probst, D.
Publicado 2019

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics

por Kristiansen, G, Fritzsche, F R, Wassermann, K, Jäger, C, Tölle, A, Lein, M, Stephan, C, Jung, K, Pilarsky, C, Dietel, M, Moch, H
Publicado 2008

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype

por Kristiansen, G, Rose, M, Geisler, C, Fritzsche, F R, Gerhardt, J, Lüke, C, Ladhoff, A-M, Knüchel, R, Dietel, M, Moch, H, Varga, Z, Theurillat, J-P, Gorr, T A, Dahl, E
Publicado 2010

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)

por Feilchenfeldt, J, Varga, Z, Siano, M, Grabsch, H I, Held, U, Schuknecht, B, Trip, A, Hamaguchi, T, Gut, P, Balague, O, Khanfir, K, Diebold, J, Jochum, W, Shoji, H, Kushima, R, Wagner, D, Shimada, Y, Cats, A, Knuth, A, Moch, H, Aebi, S, Hofer, S
Publicado 2015

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)

por Feilchenfeldt, J, Varga, Z, Siano, M, Grabsch, H I, Held, U, Schuknecht, B, Trip, A, Hamaguchi, T, Gut, P, Balague, O, Khanfir, K, Diebold, J, Jochum, W, Shoji, H, Kushima, R, Wagner, D, Shimada, Y, Cats, A, Knuth, A, Moch, H, Aebi, S, Hofer, S
Publicado 2015

Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients

por Stoehr, C G, Stoehr, R, Wenners, A, Hartmann, A, Bertz, S, Spath, V, Walter, B, Junker, K, Moch, H, Hinze, R, Denzinger, S, Bond, E E, Bond, G L, Bluemke, K, Weigelt, K, Lieb, V, Nolte, E, Fornara, P, Wullich, B, Taubert, H, Wach, S
Publicado 2016